NHS National Framework for the supply of Ustekinumab - 1 September 2024
Estimated value
—
goods
Awarded value
—
Suppliers
12
2 SME
Lots
2
12 awarded
Published
12 Sept 2024
Other contracts from NHS England· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Matrix - Desk Booking System | call off | £105k | 08 May 2026 |
| Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028 | call off | £17k | 08 May 2026 |
| ID&V Checking Service | contract | £150k | 08 May 2026 |
| Xerox Managed Print renewal 26/27 | call off | £127k | 08 May 2026 |
| Manage Engine ServiceDesk Plus Licences | call off | £29k | 08 May 2026 |
| Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026 | contract | £105k | 08 May 2026 |
| Clinicals Run Maintain Transform | call off | £38.0m | 10 Apr 2026 |
| Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmes | contract | — | 07 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 07 Apr 2026 |
| CPIT System Integration to NHSE RAVS | contract | £500k | 01 Apr 2026 |
Other contracts awarded to Amgen Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Transitional Drugs 6 | contract | — | 30 Mar 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Denosumab Injection commencing 1st January 2026 | contract | — | 04 Dec 2025 |
| Project/Contract NHS National Framework for Denosumab Injection | contract | — | 02 Oct 2025 |
| Romiplostim (Nplate®) | contract | — | 10 Sept 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 | contract | — | 29 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | contract | — | 24 Jul 2025 |